基本信息
浏览量:2
职业迁徙
个人简介
Michael Fried is a hepatologist who has performed translational and clinical studies related to viral hepatitis. He has served as the principal investigator or co-investigator on numerous phase I through phase III clinical trials that have contributed greatly to defining the treatment of chronic viral hepatitis and to characterizing direct-acting antiviral agents, which are the newest generation of therapeutics for hepatitis C. He served as Chair or co-Chair of three NIH-sponsored clinical research networks in viral hepatitis. He is currently the co-Chair of the NIH NIDDK Hepatitis B Research Network, which is performing clinical and laboratory studies of patients in different phases of hepatitis B infection. More recently, he has served as co-PI with Dr. David Nelson at University of Florida, of an international multicenter longitudinal, observational study of patients being treated for HCV at academic and community medical centers in order to understand the true real world safety and effectiveness of new treatment regimens for hepatitis C (HCV-TARGET). He has been awarded two PCORI grants (Fried, co-PI) to evaluate patient reported outcomes with HCV therapy, using the HCV-TARGET infrastructure. He received the Food and Drug Administration’s Award for Regulatory Science Excellence for HCV-TARGET.
研究兴趣
论文共 1020 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Hepatology (2023): S95-S96
引用0浏览0引用
0
0
American Journal of Transplantationno. 3 (2023): 468-478
Research Square (Research Square) (2023)
引用0浏览0引用
0
0
引用5浏览0引用
5
0
Der Gastroenterologeno. 2 (2022): 71-73
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn